MATCH SIZE AND QUANTITY
Build your comparison.
Choose a labeled amount and selection to load matching prices.
Vial comparison
Compare PNC-27 listings by strength, selection and supplier. Inspect the original source behind each price.
MATCH SIZE AND QUANTITY
Choose a labeled amount and selection to load matching prices.
GO BEYOND THE PRICE
Select a strength and selection above to view price history, save a price watch or add it to your basket.
DOCUMENTATION PASSPORTS
Inspect the source report, recorded lot and document access. A report link does not confirm the batch currently shipping.
Loading documentation records…
Reported quantities in this family: 1, 10. Counts and units must be matched to the exact listing.
Choose the labeled amount per unit and quantity before comparing. A single unit and a multipack have different upfront prices. Keep product format and exact recipe consistent; similar names do not establish equivalent products.
Follow the original listing to check its quantity, availability and current price. Unit prices use the full labeled mass in each selection.
Compare within each strength. Every row covers one vial and includes only listings marked in stock with known quantities.
| Strength | Selection | Lowest listed total price | Price per mg | Supplier count | Compare |
|---|---|---|---|---|---|
| 10 mg | 1 vial | $110.00 | $11.00 | 2 | Compare |

122 products · 249 listings

153 products · 275 listings
4 listings from direct supplier captures. Capture and import dates record when data was obtained; they do not guarantee the supplier’s current price or stock.
Listings include out-of-stock and unconfirmed-stock records. Inclusion does not certify a supplier, a batch or a product. Read how matching and source dates work.
FROM PEPTIDES CALCULATOR
Source profile reviewed 2026-10-01 · Imported 2026-10-22. Read the full compound profile
PNC-27 is a 32-amino-acid synthetic peptide that joins residues 12 to 26 of the human p53 tumour suppressor, the part that binds the HDM-2 (MDM2) protein, to penetratin, a membrane residency sequence from the Antennapedia protein. Groups at SUNY Downstate, Drexel and collaborating institutions report that cancer cells carry HDM-2 in their plasma membrane while untransformed cells do not, and that PNC-27 binds that membrane HDM-2 and forms pores, killing the cell by necrosis rather than apoptosis; cells engineered to display HDM-2 on their surface became susceptible. The compound has been tested in cancer cell lines, patient-derived ovarian tumour cells and mouse leukaemia models, but never in a human trial, and several of its investigators hold patents or company positions. In January 2017 the FDA warned consumers not to buy or use PNC-27 as a cancer treatment after finding the bacterium Variovorax paradoxus in a sample of an inhalation solution sold online.
Molecular structure and properties
Mechanism of selective cancer cell destruction
Background is reproduced from Peptides Calculator with attribution. The source describes compound-level research. It does not evaluate the identity, quality or suitability of a listed supplier’s product or batch.